Aptus Pharma IPO Details
The Aptus Pharma IPO is a book build issue with a total issue size of ₹13.02 cr Aptus Pharma IPO opened for subscription on Sep 23, 2025 and closed on Sep 25, 2025. Aptus Pharma IPO is set price band at ₹65 to ₹70 per share, with a lot size of 200 shares. Minimum investment for Retail investors was ₹28,000.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Sep 26, 2025, and listed on both the NSE and BSE on Sep 30, 2025.
Bigshare Services Pvt Ltd has been appointed as the registrar. Interactive Financial Services Ltd are the Book Running Lead Manager for the issue.
Before investing in the Aptus Pharma IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 65 – 70
- Lot Size
- 200
- Issue Size
- ₹13.02 Cr
- Minimum Investment
- ₹28000 (400 Shares)
- Listing Date
- 30 September 2025
Current GMP
₹4 (+5.71%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Aptus Pharma Limited
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations
The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.
Products:
- Aptus Pharma: Focuses on acute therapies i.e, anti-infectives, pain management, etc.
- Aptus CD care: Focused on chronic therapies
- Aptus Wellcare: Offers wellness and nutraceutical products
- Aptus Global: Export in overseas market
As of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments.
Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel.
As of March 31, 2025, the company had 70 employees.
Aptus Pharma IPO Promoters
- Tejash Maheshchandra Hathi
- Chatrabhuj Vallabhbhai Butani
- Kapilbhai Hasmukhbhai Chandarana
- Ghanshyam Vinubhai Pansuriya
- Milly Chetan Lalseta
- Riddhish Natwarlal Tanna
- Gaurang Rameshchandra Thakker
- Kripaliben Mayank Thakker
- Kunjal Piyushbhai Unadkat
Promoters Holding
Holding Pre Issue
100.00%
Holding Post Issue
72.89%
Aptus Pharma IPO Objective
The Company Aptus Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Capital Expenditure for Office Premises with furniture and Industrial Racks
- Working Capital
- General corporate purposes
Address / Contact Info
Aptus Pharma Ltd.
Ashutosh Buildcon, Opp. Slok - 2,
Nr. Harikrupa Logistic Park,
Aslali, Ahmedabad, Daskroi,
Ahmedabad, Gujarat, 382427
Phone: +91 76004 27827
Email: info@aptuspharma.com
Website: https://aptus-pharma.com/
IPO Snapshot
Book Running Lead Managers
- Interactive Financial Services Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Aptus Pharma IPO is a Book-building IPO with a total issue size of ₹13.02 crore. The Aptus Pharma IPO price band is ₹65 to 70 per share. The Aptus Pharma IPO subscription opens on Tue, Sep 23, 2025, and closes on Thu, Sep 25, 2025. The Aptus Pharma IPO will be listed on the BSE. Bigshare Services Pvt Ltd is the registrar for the Aptus Pharma IPO.
The Aptus Pharma IPO opens on Tue, Sep 23, 2025 and closes on Thu, Sep 25, 2025
Aptus Pharma IPO Price Band is ₹65 to 70 per share.
Aptus Pharma IPO lot size is 200 shares, Retail investors need a minimum investment of ₹28000 based on the upper price band
The minimum investment for Aptus Pharma IPO is ₹28000, based on one lot of 200 shares at the upper price band of ₹70 per share.
Investors can apply for the Aptus Pharma IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Thu, Sep 25, 2025. The application amount remains blocked until the Aptus Pharma IPO allotment is finalized.
Aptus Pharma IPO issue size is ₹13.02 crores.
Aptus Pharma IPO allotment date is Wed, Jul 1, 2026.
The registrar for Aptus Pharma IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Aptus Pharma IPO allotment status, refund processing, and other IPO-related information.
The Aptus Pharma IPO GMP (Grey Market Premium) is ₹4 as of Tue, Sep 30, 2025. Based on the upper price band of ₹70 per share, the estimated Aptus Pharma IPO listing price is ₹74, indicating a potential listing gain of approximately 0% over the issue price.